05.05.2021 22:10:39
|
Rigel Pharmaceuticals Inc. Bottom Line Rises In Q1
(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) revealed a profit for its first quarter that rose from the same period last year.
The company's earnings totaled $39.50 million, or $0.22 per share. This compares with $21.24 million, or $0.13 per share, in last year's first quarter.
Analysts had expected the company to earn $0.00 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 45.3% to $81.02 million from $55.76 million last year.
Rigel Pharmaceuticals Inc. earnings at a glance:
-Earnings (Q1): $39.50 Mln. vs. $21.24 Mln. last year. -EPS (Q1): $0.22 vs. $0.13 last year. -Analysts Estimate: $0.00 -Revenue (Q1): $81.02 Mln vs. $55.76 Mln last year.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Rigel Pharmaceuticals IncShsmehr Nachrichten
Keine Nachrichten verfügbar. |